Industrial drug development: application of the theoretical framework of Abernathy, Clark, and Kantrow (1983) in an analysis of factors which determine productivity

Simple item page
dc.contributor.authorGriffiths, Robert Ianen
dc.contributor.committeechairPitt, Joseph C.en
dc.contributor.committeememberPaterson, Robert A.en
dc.contributor.committeememberMullins, Nicholas C.en
dc.contributor.committeememberDowney, Gary L.en
dc.contributor.committeememberHirsh, Richard F.en
dc.contributor.departmentScience and Technology Studiesen
dc.date.accessioned2014-03-14T21:33:37Zen
dc.date.adate2010-04-12en
dc.date.available2014-03-14T21:33:37Zen
dc.date.issued1988-05-31en
dc.date.rdate2010-04-12en
dc.date.sdate2010-04-12en
dc.description.abstractThis study identifies and analyzes factors which determine productivity in the drug industry. It shares a general concern about recent decline in industrial productivity in the United States with Abernathy, Clark, and Kantrow (1983), who developed a theoretical framework for analyzing the causes of lackluster industrial performance. According to Abernathy, et al. (1983), performance is determined by government fiscal and monetary policy, production capability, socioeconomic environment,(of which regulation is a subset), and corporate management. This study finds that the theoretical framework of Abernathy et al (1983) can be used as a context for analyzing productivity in the drug industry. In a recent case of drug development, socioeconomic and managerial problems caused costly delays in development, hampering the company's capacity to be productive. The study also finds that the strategy for industrial revitalization developed by Abernathy et al. (1983) is applicable to the drug industry. Specifically, corporate management must integrate the development activities of innovation, production, finance, and marketing more efficiently. More efficient integration will help management to consider the impact of one activity on the others, and to identify deficiencies which can delay development. This will help management cut development time and increase profits, which will help revitalize the drug industry.en
dc.description.degreeMaster of Scienceen
dc.format.extentv, 63 leavesen
dc.format.mediumBTDen
dc.format.mimetypeapplication/pdfen
dc.identifier.otheretd-04122010-083717en
dc.identifier.sourceurlhttp://scholar.lib.vt.edu/theses/available/etd-04122010-083717/en
dc.identifier.urihttp://hdl.handle.net/10919/42048en
dc.publisherVirginia Techen
dc.relation.haspartLD5655.V855_1988.G744.pdfen
dc.relation.isformatofOCLC# 18609781en
dc.rightsIn Copyrighten
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/en
dc.subject.lccLD5655.V855 1988.G744en
dc.subject.lcshDrugs -- Law and legislationen
dc.subject.lcshPharmaceutical industryen
dc.titleIndustrial drug development: application of the theoretical framework of Abernathy, Clark, and Kantrow (1983) in an analysis of factors which determine productivityen
dc.typeThesisen
dc.type.dcmitypeTexten
thesis.degree.disciplineScience and Technology Studiesen
thesis.degree.grantorVirginia Polytechnic Institute and State Universityen
thesis.degree.levelmastersen
thesis.degree.nameMaster of Scienceen

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
LD5655.V855_1988.G744.pdf
Size:
2.06 MB
Format:
Adobe Portable Document Format
Download

Collections

Masters Theses